Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Gastroenterology
|
October 27, 1999
Characterization of Helicobacter pylori PldA, a phospholipase with a role in colonization of the gastric mucosa
N Dorrell, M C Martino, R A Stabler, et al.
The Journal of Antibiotics
|
April 1, 1994
WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. II. Biological activity
J J Oleynek, D M Sedlock, C J Barrow, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1989
A role for histamine and H2-receptors in opioid antinociception
K R Gogas, L B Hough, N B Eberle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1990
Pharmacology of pravadoline: a new analgesic agent
D R Haubrich, S J Ward, E Baizman, et al.
Heredity
|
November 13, 2001
Association analysis of IL1A and IL1B variants in alopecia areata
R Tazi-Ahnini, A J McDonagh, A Cox, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 1994
The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist
D G Sawutz, J M Salvino, R E Dolle, et al.
Pharmacology, Biochemistry, and Behavior
|
November 1, 1991
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
B R Martin, D R Compton, B F Thomas, et al.
Journal of Medicinal Chemistry
|
January 1, 1992
Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor
T E D'Ambra, K G Estep, M R Bell, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 11, 2007
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use
S Xie, M A Furjanic, J J Ferrara, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Gastroenterology
|
October 27, 1999
Characterization of Helicobacter pylori PldA, a phospholipase with a role in colonization of the gastric mucosa
N Dorrell, M C Martino, R A Stabler, et al.
The Journal of Antibiotics
|
April 1, 1994
WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. II. Biological activity
J J Oleynek, D M Sedlock, C J Barrow, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1989
A role for histamine and H2-receptors in opioid antinociception
K R Gogas, L B Hough, N B Eberle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1990
Pharmacology of pravadoline: a new analgesic agent
D R Haubrich, S J Ward, E Baizman, et al.
Heredity
|
November 13, 2001
Association analysis of IL1A and IL1B variants in alopecia areata
R Tazi-Ahnini, A J McDonagh, A Cox, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 1994
The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist
D G Sawutz, J M Salvino, R E Dolle, et al.
Pharmacology, Biochemistry, and Behavior
|
November 1, 1991
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
B R Martin, D R Compton, B F Thomas, et al.
Journal of Medicinal Chemistry
|
January 1, 1992
Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor
T E D'Ambra, K G Estep, M R Bell, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 11, 2007
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use
S Xie, M A Furjanic, J J Ferrara, et al.
Page
of 11